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 Abstract 
 Background: Advanced glycation end products (AGEs), 
the final products of the Maillard reaction, have been 
shown to impair endothelial proliferation and func-
tion, thus contributing to endothelial cell injury present 
in diabetes, inflammatory and cardiovascular diseases. 
Endoplasmic reticulum (ER) stress triggered under hyper-
glycemic, hypoxic and oxidative conditions has been 
implicated in endothelial dysfunction through activa-
tion of the unfolded protein response (UPR). The present 
study investigates the role of AGEs in ER stress induction 
in human aortic endothelial cells exposed to variable AGE 
treatments. 
 Methods: Human aortic endothelial cells (HAEC) were 
treated with increasing concentrations (100, 200  μ g/mL) 
of AGE-bovine serum albumin (AGE-BSA) at different 
time-points (24, 48, 72 h). The induction of ER stress 
and the involved UPR components were investigated on 
mRNA and protein levels. Apoptosis was quantitatively 
determined by flow cytometry detecting propidium iodide 
expression and annexin V binding simultaneously. 
 Results: AGEs administration significantly reduced HAEC 
proliferation in a time- and dose-dependent manner. An 
immediate induction of the ER chaperones GRP78, GRP94 
and the transcriptional activator, XBP-1 was observed at 
24 h and 48 h. A later induction of the phospho-elF2 α and 
proapoptotic transcription factor CHOP was observed at 
48 h and 72 h, being correlated with elevated early apop-
totic cell numbers at the same time-points. 
 Conclusions: The present study demonstrates that AGEs 
directly induce ER stress in human aortic endothe-
lial cells, playing an important role in endothelial cell 
apoptosis. Targeting AGEs signaling pathways in order to 
alleviate ER stress may prove of therapeutic potential to 
endothelial dysfunction-related disorders. 
 Keywords:  advanced glycation end-products (AGEs);  apo-
ptosis;  endoplasmic reticulum (ER) stress;  human aortic 
endothelial cells;  unfolded protein response (UPR). 
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 Introduction 
 Advanced glycation end products (AGEs) are highly reac-
tive molecules resulting from the irreversible post-trans-
lational modification reactions of glucose with the amino 
groups on proteins, lipids or nucleic acids [ 1 ,  2 ]. Increased 
circulating AGE levels are a common finding and a 
pathogenic mediator of hyperglycemic, oxidative and 
inflammatory conditions including diabetes, polycystic 
ovarian syndrome, neurodegenerative and cardiovascular 
diseases [ 3 – 6 ]. However, exogenous intake of AGEs from 
high fat and/or protein diets, beverages or cigarette smoke 
may also contribute to increased AGEs tissue deposition 
under normal physiology predisposing individuals to meta-
bolic, cardiovascular disorders and progressive aging 
[ 7 ,  8 ]. AGEs have been shown to accumulate in almost all 
major organs including vascular tissues mediating both 
extracellular and intracellular functions [ 9 ]. 
 Endothelial cells (ECs) have been proposed as primary 
targets of AGEs, affecting their proliferation, migration and 
adhesion [ 10 ]. Extracellular effects of AGEs in endothe-
lium involve irreversible crosslinking formation with 
stable, long-lived extracellular matrix proteins such as col-
lagen, elastin or laminin [ 11 ]. At the same time they can 
induce cell activation, proinflammatory cytokine release 
and oxidative stress through interaction with their recep-
tor, RAGE, leading to endothelial injury and dysfunction 
[ 12 ,  13 ]. The role of AGEs in the induction of aortic endothe-
lial apoptosis has not been adequately addressed. It has 
been suggested that AGEs trigger oxidative stress and thus 
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accelerate apoptosis of bovine aortic ECs contributing to 
vascular complications associated with diabetes mellitus 
[ 14 ]. This effect has been attributed to AGE-RAGE interac-
tion leading to increased intracellular accumulation of 
reactive oxygen species and elevation of intracellular Ca 2 +  
concentration. Additionally, AGE-RAGE dependent activa-
tion promotes apoptosis of rat endothelial progenitor cells 
and inhibits their migration [ 15 ]. Recently methyglyoxal, 
the main AGE precursor has also been shown to induce 
apoptosis of human aortic endothelial cells (HAEC), 
through oxidative stress and by triggering the mitochon-
drial route of apoptotic machinery [ 16 ]. 
 Relevant studies challenge the central role of mito-
chondria in apoptosis and suggest that some apoptotic 
signals may bypass mitochondria to directly activate 
caspases [ 17 ]. Endoplasmic reticulum (ER) stress pre-
sents such an alternative mechanism triggering apoptosis 
without the involvement of mitochondria [ 18 ]. ER is the 
major organelle involved in the synthesis and folding of 
secreted and membrane bound proteins, calcium home-
ostasis and lipid biosynthesis [ 19 ]. The lumen of ER is 
characterized by high Ca 2 +  concentration and a very oxi-
dizing environment [ 19 ]. Stressors that interfere with the 
ER functions, such as oxidant or reducing agents, result in 
the disruption of Ca 2 +  homeostasis or glucose deprivation 
leading to the accumulation of unfolded and/or misfolded 
proteins in the ER lumen, known as ER stress [ 20 ]. 
 The mammalian ER stress response known as unfolded 
protein response (UPR) can be separated into two phases, 
adaptation and apoptosis. The cells initially adapt to the 
accumulation of unfolded proteins by increasing the con-
centration of chaperones in the ER lumen, namely the glu-
cose-regulated protein 78 (GRP78) and glucose-regulated 
protein 94 (GRP94). The UPR response is triggered by 
the activation of three main sensors of ER stress: protein 
kinase-like ER kinase (PERK), inositol requiring kinase 1 
(IRE1) and the activating transcription factor 6 (ATF6) [ 20 ]. 
All these proteins are maintained in the inactive form by 
binding the N-terminus of GRP78 that serves both as chap-
erone and sensor of ER stress. When misfolded proteins 
accumulate, GRP78 is required for its chaperone function 
and releases these sensors to initiate the UPR [ 21 ]. PERK, 
upon activation, phosphorylates the eukaryotic transla-
tion initiation factor 2 α (eIF2 α ), decreases mRNA transla-
tion and induces UPR-related genes [ 20 ]. Similarly, activa-
tion of IRE1 α and ATF6 also leads to regulation of various 
UPR-related genes, such as protein chaperones and cal-
nexin [ 22 ]. However, if this adaptation does not prove suf-
ficient, the apoptotic response is initiated. 
 Previous studies have shown that ER stress is impli-
cated in endothelial dysfunction associated with diabetes 
mellitus and cardiovascular diseases indicating that ER 
stress-induced apoptosis can be an important patho-
physiological factor [ 23 ,  24 ]. Furthermore, AGEs have been 
shown to induce ER stress-mediated apoptosis in mouse 
podocytes [ 25 ], human neuroblastoma cells and corti-
cal neurons [ 26 ]. However, the role of AGEs in ER stress-
induced apoptosis in human aortic ECs remains to be 
elucidated. The present study aims to delineate ER stress 
induction in human ECs exposed to different AGE concen-
trations at variable time-points, monitoring the series of 
events leading to apoptosis. 
 Materials and methods 
 Reagents 
 All reagents were purchased from Life Technologies (Carlsbad, CA, 
USA) unless otherwise stated. AGE-bovine serum albumin (AGE-BSA) 
was obtained from Abcam plc (ab51995; Cambridge, UK). Tunica-
mycin was purchased from AppliChem (Darmstadt, Germany). BSA, 
TNF- α and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) were obtained from Sigma Aldrich (St Louis, MO, USA). 
 AGE-BSA characteristics 
 According to manufacturer ’ s instructions, glycated BSA has been 
produced by reacting BSA with glycoaldehyde under sterile condi-
tions followed by extensive dialysis and purifi cation steps. Fluores-
cence of AGEs was confi rmed by fl uorescence spectrophotometry 
with Ex./Em. = 370/440 nm. Glycated BSA showed 7000% increase in 
fl uorescence when compared to control BSA. The purity of the fi nal 
stock is  > 95% as analyzed by SDS-PAGE and fi lter sterilized using 
0.22  μ m fi lter. 
 Culture of endothelial cells 
 HAEC were obtained as cryopreserved cells from European Collection 
of Cell Cultures (ECACC) and were cultured in endothelial cell growth 
medium M200 supplemented with Low Serum Growth Supplement 
containing Fetal Bovine Serum (2% v/v), hydrocortisone, (1 g/mL), 
human epidermal growth factor (10 ng/mL), basic fi broblast growth 
factor, (3 ng/mL), heparin (10 g/mL), gentamicin (50  μ g/mL) and am-
photericin B (50 ng/mL). Cells were cultured at 37 ° C in a humidifi ed 
95% air  – 5% CO 2 atmosphere and were split according to standard 
procedures. HAEC were used in all assays between passage four and 
eight. 
 Cell proliferation assay 
 For the proliferation assay, HAEC were plated on 96-well microplates 
at a density of approximately 1 × 10 4 cells per well, and then treated 
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with either unmodifi ed BSA or AGE-BSA at concentrations of 100 
and 200  μ g/mL for 24, 48 and 72 h or with tunicamycin at concentra-
tion of 5  μ g/mL for 24 h. Co-treatment with both tunicamycin at the 
same concentration and AGE-BSA at concentrations of 100, 200 and 
400  μ g/mL was also performed. Cell viability was subsequently 
determined by the MTT assay as described previously [ 27 ]. Each 
experiment was conducted in triplicate. 
 RT-PCR analysis 
 Total RNA was isolated from cultured cells using RNeasy Mini Kit 
(Qiagen, Hilden, Germany), according to the manufacturer ’ s instruc-
tions. cDNA was synthesized in a two-step reaction using iScript 
cDNA synthesis kit (Biorad, Hercules, CA, USA). 
 For semi-quantitative PCR, cDNA was amplifi ed using gene spe-
cifi c primer pairs in 25 cycles. Detailed PCR conditions have been de-
scribed previously [ 28 ]. PCR fragments were resolved on EtBr agarose 
gel. Densitometric analysis of PCR fragments was performed using 
image analysis soft ware Image J (La Jolla, CA, USA) aft er normaliza-
tion to actin levels. All experiments have been performed at least 
three times. Data and densitometric analysis from one representative 
experiment are presented. 
 Real-time quantitative PCR 
 Real-time quantitative PCR was performed using an iCycler real time 
instrument (Biorad). RT-PCR product was amplifi ed using the iQ SYBR 
Green Supermix (Biorad) in a total reaction volume of 20  μ L. Primer 
effi  ciencies were calculated from a standard curve of serially diluted 
cDNA. Product identity was confi rmed by a single pick in the melt 
curve. Relative expression values were calculated using the 2  − ( Δ Δ Ct) 
formula. The data are presented as fold change in gene expression 
normalized to GAPDH and relative to the untreated control. The prim-
ers used for the amplifi cation of  CHOP were forward 5 ′ -agtgccacgga-
gaaagctaa-3 ′ , and reverse primer, 5 ′ -ccatacagcagcctgagtga-3 ′ , and for 
GAPDH were forward primer 5 ′ -gggtgtgaaccatgagaagt-3 ′ , and reverse 
primer 5 ′ -catgccagtgagcttcccgttc-3 ′ . 
 Western blot analysis 
 For immunoblot analysis cells were solubilized with ice-cold 
RIPA buffer (Thermo Scientific, Rockford, IL, USA) supplemented 
with protease inhibitor cocktail (Thermo Scientific). The protein 
concentration in the lysates was determined by using Bradford 
assay (Biorad). Equal amounts of total protein were resolved by 
SDS-PAGE and immunoblotted with anti-GRP78 (#3177S; Cell 
Signaling, Beverly, MA, USA), anti-CHOP (sc-71817; Santa Cruz 
Biotechnology, Santa Cruz, CA, USA), anti-p-eIF2 α (#33985; Cell 
Signaling), anti-XBP-1 (sc-7160; Santa Cruz) and anti-Actin (MAB-
150; Millipore, Bedford, MA, USA). Relative protein amounts were 
evaluated by a densitometric analysis using Image J software and 
normalized to the corresponding actin levels. All experiments 
have been performed at least three times and representative re-
sults and the corresponding quantification data of one experiment 
are shown. 
 Assessment of apoptosis by flow cytometry 
 For the apoptosis assay, HAEC were seeded in six-well plates at a den-
sity of approximately 2 × 10 5 cells per well and then treated with BSA 
or AGE-BSA at a concentration of 200  μ g/mL for 48 h and 72 h, with 
tunicamycin at a concentration of 5  μ g/mL for 24  h and with both 
AGE-BSA and tunicamycin at the same concentrations for 24 h. Cells 
were then harvested, rinsed twice with PBS, collected by centrifuga-
tion at 2000 rpm for 5 min and annexin V-FITC apoptosis detection 
kit (Trevigen, Gaithersburg, MD, Germany) was used according to the 
manufacturer ’ s protocol. Samples were scanned with a fl uorescence-
activated cell sorter (FACSCalibur, Becton Dickinson, USA), and the 
data were analyzed with CellQuest soft ware (Becton Dickinson). 
A total of 10,000 events were measured per sample. 
 Plots in the annexin V-positive/propidium iodide-negative 
quadrant were counted as apoptotic cells. Each experiment was per-
formed in triplicate. 
 Statistics 
 The data are presented as mean  ± SE for the number of experiments 
indicated. Statistical analysis of the results was performed using Stu-
dent ’ s t-test. A p-value of  < 0.05 was considered to indicate statistical 
signifi cance. 
 Results 
 AGE-BSA administration inhibited 
HAEC proliferation in a time- and 
dose-dependent manner 
 In order to elucidate the impact of AGEs in endothelial 
cell proliferation, HAEC were treated with increasing 
concentrations (100, 200  μ g/mL) of unmodified bovine 
serum albumin (BSA) or AGE-BSA for different periods 
of time (24, 48, 72 h). MTT proliferation assay indi-
cated that AGEs administration significantly reduced 
HAEC viability in a time- and dose-dependent manner 
(48  h – 100  μ g/mL AGE-BSA: p < 0.01; 48  h – 200  μ g/mL 
AGE-BSA: p < 0.05; 72  h – 100  μ g/mL AGE-BSA: p < 0.05; 
72h – 200  μ g/mL AGE-BSA: p < 0.001) ( Figure 1 A). In addi-
tion the administration of the ER stress-inducer tunica-
mycin had the same effect with the higher concentration 
dose of AGE-BSA (200  μ g/mL) and longer incubation 
time (72 h) (p < 0.001). The combined administration of 
tunicamycin and increasing concentrations of AGE-BSA 
indicated minor reduction of HAEC proliferation sug-
gesting a non-synergistic effect between these two 
agents ( Figure 1 B). 
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 AGE-BSA treatment-induced ER stress 
in HAEC 
 Based on recent studies that describe the involvement of 
AGEs in ER stress signaling, we investigated the possible 
induction of ER stress and the expression of UPR components 
upon AGE-BSA administration. Semi quantitative PCR analy-
sis demonstrated the up-regulation of chaperones GRP78 
and GRP94, the major indicators of ER stress induction in 
all conditions under study ( Figure 2 ). We also observed an 
increase in  XBP-1 mRNA levels at early time points (24 h, 
48 h) and lower concentrations  − 100  μ g/mL) and of the 
spliced form of  XBP-1 at 72 h, suggesting the early activation 
of IRE-1 pathway upon AGEs presence ( Figure 2 B – D). 
 Furthermore, we assessed the protein levels of the 
early GRP78, XBP-1 and late UPR effectors, p-eIF2 α and 
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 Figure 1   Inhibition of HAEC proliferation by AGE-BSA and tunicamy-
cin treatment. 
 (A) Cells treated with BSA or AGE-BSA at concentrations of 100 and 
200  μ g/mL for 24 h, 48 h and 72 h were subjected to the MTT cell 
proliferation assay. (B) Independent experiments with combined 
administration of tunicamycin (5  μ g/mL) for 24 h and increasing 
concentration of AGE-BSA (100 – 400  μ g/mL) were performed. The 
viability of untreated cells (control) was considered 100%. *p < 0.05, 
**p < 0.01, ***p < 0.001. 
CHOP following AGE-BSA incubation. GRP78 expression 
was found to be up-regulated in all dose- and time-points 
( Figure 3 ) being in accordance with the elevated mRNA 
levels ( Figure 2 ). Similar trend was also observed in XBP-1 
protein expression levels that remained elevated at early 
time points (24 h, 48 h) and decreased at 72  h at both 
AGE-BSA concentrations ( Figure 3 ). In order to investigate 
the involvement of late UPR effectors in AGEs-induced ER 
stress, key molecules of the PERK pathway were studied. 
As shown in  Figure 3 , AGE-BSA administration in HAEC 
increased the phosphorylated form of eIF2 α and of the 
pro-apoptotic transcription factor CHOP expression in a 
time- and dose- dependent manner. Higher levels were 
observed in 48 h (200  μ g/mL AGE-BSA) and in 72 h (at both 
concentrations). 
 AGE-BSA administration-induced ER 
stress-mediated apoptosis in HAEC 
 In order to confirm the proapoptotic transcription factor 
CHOP induction upon AGEs treatment, we monitored 
 CHOP mRNA expression levels using quantitative real 
time PCR analysis. Our results demonstrated an even 
higher statistically significant  CHOP mRNA fold induction 
compared with protein expression levels in 72 h treatment 
at both concentrations ( Figure 4 ). 
 This finding indicated the development of CHOP-
mediated apoptosis in HAEC upon AGEs treatment that 
was further investigated by annexin V/propidium iodide 
flow cytometric analysis ( Figure 5 ). High concentration of 
AGEs (200  μ g/mL) for 48 h and 72 h incubation resulted 
in a significant increase of the early apoptotic fraction 
of HAEC (four- and eight-fold, respectively). In addition 
tunicamycin and AGE-BSA co-treatment did not further 
increase the early apoptotic cells compared to tunicamy-
cin alone (39.64% vs. 37.51% of gated cells). This result is 
consistent with the proliferation data ( Figure 1 B), provid-
ing further evidence for a common mechanism between 
AGEs and tunicamycin in inducing HAEC apoptosis via 
activation of UPR signaling. 
 Discussion 
 Endothelial cells present primary dynamic structures 
that actively regulate basal vascular tone and reactivity in 
physiological and pathological conditions. They respond 
to neurohumoral mediators and mechanical forces as 
to maintain the balance between vasodilatation and 
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vasoconstriction, restore blood fluidity and vessel wall 
integrity [ 29 ]. Loss of endothelial function may be a criti-
cal and initiating factor for several conditions including 
inflammation, diabetic micro- and macrovascular compli-
cations as well as cardiovascular diseases [ 29 ]. 
 AGEs have been shown to contribute to endothelial 
dysfunction and this has been clearly demonstrated in 
diabetes, where levels of serum AGEs in patients with type 
2 diabetes were negatively associated with the degree of 
endothelium-dependent and endothelium independent 
vasodilation [ 30 ]. Several mechanisms have been sug-
gested to explain the association. Among them, bioavaila-
bility and activity of the endothelium-derived NO has been 
demonstrated to be reduced by AGEs [ 31 ]. AGE associated 
induction of oxidative stress may quench and inactivate 
endothelium-derived NO and uncouple endothelial NO 
synthase (eNOS) activity through receptor-mediated phos-
phorylation and increased eNOS degradation [ 32 ,  33 ]. In 
addition, AGEs may impair endothelial balance by reduc-
ing the endothelial production of prostacyclin [ 34 ] and 
enhancing the expression of endothelin-1 [ 35 ]. They are also 
capable of increasing endothelial permeability to macro-
molecules [ 36 ,  37 ] and modify the functions of endothelial 
progenitor cells by promoting their apoptosis and migra-
tion [ 38 ]. Endothelial cell apoptosis due to AGEs has been 
demonstrated in several studies using bovine and human 
aortic ECs and has been mainly attributed to the induction 
of oxidative stress and mitochondrial dysfunction [ 14 ,  16 ]. 
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 Figure 2   AGE-BSA administration induces mRNA levels of UPR components in HAEC. 
 (A) ER stress induction in HAEC following AGE-BSA treatment. RT-PCR analysis of  GRP78, GRP94 and  XBP-1 mRNA expression after AGE-BSA 
administration at increasing concentrations (100, 200  μ g/mL) for different periods of time (24 h, 48 h, 72 h). The lower band represents the 
spliced form of activated  XBP-1(arrow). (B) The panel represents results of densitometric analysis of  GRP78, GRP94 and  XBP-1 PCR fragments 
after normalization to actin levels. TNF- α (50 ng/mL for 4 h) and tunicamycin (5  μ g/mL for 24 h) treatments were used as positive ER stress 
induction controls. All experiments have been performed at least three times and representative results as well as corresponding quantifi-
cation data of one experiment are shown (B – D). 
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 Here, we show AGEs-induced apoptosis in ECs through 
ER stress pathway, providing a novel molecular mecha-
nism for endothelial dysfunction in metabolic and cardio-
vascular disorders. ER is exquisitely sensitive to glucose 
availability and depends on blood glucose levels for the 
energy supply required for the protein folding process [ 39 ]. 
ECs always exposed to elevations and reductions of blood 
nutrients, are very dynamic, metabolically active cells, 
with a high volume of protein synthesis which predispose 
them to ER stress [ 40 ]. In particular ECs cannot tolerate 
the continued high glucose exposure, and thus ER stress 
is commonly initiated in a diabetic milieu [ 41 ]. It was thus 
hypothesized that ER stress may also be induced in HAECs 
under conditions of increased exogenous glycated proteins 
(AGEs) uptake. Indeed, incubation of HAEC with high AGE 
levels for prolonged durations (48 h and 72 h) was capable 
to significantly reduce cell proliferation. This reduc-
tion was accompanied by increased mRNA and protein 
levels of ER stress sensors (GRP78, GRP94) indicative of 
ER stress induction. Recent studies have also shown the 
direct induction of ER stress by AGEs in murine podocytes, 
human neuroblastoma cell lines and human chondrocytes 
where they are implicated in inflammatory and oxidative 
processes as well as cell death pathways [ 25 ,  26 ,  42 ]. 
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 Figure 3   AGE-BSA administration increases GRP78 and other UPR component protein levels. 
 GRP78, p-eIF2 α , XBP-1 and CHOP protein levels were assessed by Western blot analysis after AGE-BSA treatment of HAEC at increasing 
concentrations (100, 200  μ g/mL) for various time points (24 h, 48 h, 72 h) (A). The densitometric quanti ﬁ cation of these results (normalized 
to the actin levels) is shown in the graph (B). Tunicamycin (5  μ g/mL for 24 h) treatment was used as positive ER stress induction control. 
All experiments have been performed at least three times and representative results as well as corresponding quantification data of one 
experiment are shown. 
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 Figure 4   Induction of proapoptotic transcription factor CHOP upon 
AGE-BSA treatment. 
 CHOP mRNA levels were monitored by quantitative real time PCR 
analysis in HAEC following treatment with AGE-BSA at increasing 
concentrations (100, 200  μ g/mL) for different time points. TNF- α 
(50 ng/mL for 4 h) and tunicamycin (5  μ g/mL for 24 h) treatments 
were used as positive ER stress induction controls. *p < 0.05, 
**p < 0.01, ***p < 0.001. 
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 Figure 5   AGE-BSA induced apoptosis in HAEC in a time-dependent manner. 
 Apoptosis of HAEC was determined by annexin V/PI binding. HAEC were untreated (A), treated with AGE-BSA (200  μ g/mL) for 48 h (B) and 
72 h (C), with tunicamycin (5  μ g/mL) for 24 h (D) and with both tunicamycin (5  μ g/mL) and AGE-BSA (200  μ g/mL) for 24 h (E). Percentage of 
gated cells is shown in each quadrant (UL: % of necrotic cells, UR: % of apoptotic cells, LL: % of viable cells, LR: % of early apoptotic cells). 
 Notably, at early time points (24 h, 48 h) of AGE-BSA 
administration, activation of the transcriptional activa-
tor, XBP-1 was observed that is a mediator of the adaptive 
UPR response. The three UPR branches (IRE1, PERK, and 
ATF6) have been reported to initially promote cell survival 
by reducing misfolded protein levels but when ER stress 
is not alleviated UPR signaling promotes apoptotic cell 
death. This is also possible to occur under AGEs accumu-
lation, being capable of triggering both protective and cell 
death responses depending on their concentration and 
the duration of their presence. In accordance with this 
hypothesis, we found that IRE1 activity (as demonstrated 
by XBP-1 expression) was increased at early AGE-induced 
ER stress (24 h) and attenuated by persistent ER stress 
(48 h, 72 h). IRE1 is a transmembrane kinase (endoribo-
nuclease, RNAse) that upon activation, initiates the non-
conventional splicing of  Xbp-1 mRNA [ 43 ,  44 ]. Spliced 
 Xbp-1 mRNA encodes a transcription activator that drives 
transcription of genes such as ER chaperones, whose 
products directly participate in ER protein folding [ 45 ]. 
By contrast, our data show that PERK signaling including 
translational inhibition (by phosphorylation of elF2 α ) 
and proapoptotic transcription regulator CHOP induction 
was maintained at 48 h and 72 h incubation with AGEs. 
PERK is a transmembrane kinase that phosphorylates the 
eukaryotic translation initiation factor 2 α   (elF2 α ), thus 
reducing protein synthesis and counteracting ER protein 
overload [ 46 ]. Additionally, CHOP is a B-ZIP transcrip-
tion factor induced by the PERK branch of the UPR that 
promotes cell death [ 47 ].  Chop mRNA levels were signifi-
cantly increased at 48 h incubation with 200  μ g/mL AGEs 
compared to untreated control and remained elevated at 
72  h at both concentrations, indicative of proapoptotic 
signaling. These data were further confirmed by double 
staining flow cytometric analysis of AGE-stimulated HAEC 
using the early apoptotic marker, annexin V and nucleic 
acid stain, propidium iodide. Significantly increased cell 
numbers of early apoptotic cells were detected following 
AGEs treatment for 48  h and 72 h. The modest increase 
in early and late apoptotic cell population after treatment 
with AGEs combined with tunicamycin compared to tuni-
camycin alone indicated that both agents share common 
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UPR signaling pathways in the induction of apoptosis in 
HAEC. 
 Several studies in other cell systems suggest that 
apoptosis mediated by AGEs could be induced by an ER 
pathway independent from mitochondria [ 25 ,  48 ]. More 
specifically, AGE-induced GRP78 expression as an ER 
stress sensor was associated with elevated intracellular 
Ca 2 +  and apoptosis in murine podocytes [ 25 ]. Addition-
ally, 3-deoxyglucosone, a precursor for AGEs, that is 
highly upregulated in skin explants of diabetic cutaneous 
wounds, was found to mediate ER stress-induced apopto-
sis through ROS formation in human dermal fibroblasts 
via a RAGE-independent mechanism [ 48 ]. This is par-
ticularly interesting since previous studies limited AGE-
induced apoptosis in being mediated through increased 
oxidative stress following interaction of AGEs with their 
receptor RAGE [ 14 – 16 ]. 
 It is therefore evident that due to the heterogeneity 
of AGE compounds and the wide range of their precursor 
molecules; different signaling may be selected depending 
not only upon the cell type but the state of AGE molecules 
being either in circulating or protein-bound form. Further 
research is required in elucidating the necessity of RAGE 
in endothelial ER stress induction under high AGE envi-
ronments. Additionally, since ER stress regulates mito-
chondrial bioenergetics, a potential crosstalk between 
oxidative stress in ER stress-induced apoptosis cannot be 
excluded and should be explored in detail. 
 However, our data show that ER function can be 
modulated by AGEs affecting critically both ECs func-
tionality and cell fate. Thus, chemical enhancement 
of ER function to cope with cell apoptosis provides an 
interesting approach to managing endothelial dysfunc-
tion. Pharmaceutical or chemical chaperones such as 
trimethylamine N-oxide dehydrate, 4-phenyl butyric acid 
and taurine-conjugated ursodeoxycholic acid are repre-
sentatives of a group of low-molecular weight compounds 
known to stabilize protein conformation that improve ER 
folding capacity and facilitate trafficking of mutant pro-
teins [ 49 ,  50 ]. The effectiveness of these molecules in alle-
viating endothelial injury either alone or in conjunction 
with standard medications remains to be investigated. 
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